208 related articles for article (PubMed ID: 22484226)
21. The three most common human papillomavirus oncogenic types and their integration state in Thai women with cervical precancerous lesions and carcinomas.
Aromseree S; Chaiwongkot A; Ekalaksananan T; Kongyingyoes B; Patarapadungkit N; Pientong C
J Med Virol; 2014 Nov; 86(11):1911-9. PubMed ID: 25091234
[TBL] [Abstract][Full Text] [Related]
22. Risk factors of invasive cervical cancer in Morocco.
Meftah el khair M; Ait Mhand R; Mzibri ME; Ennaji MM
Cell Mol Biol (Noisy-le-grand); 2009 Nov; 55 Suppl():OL1175-85. PubMed ID: 20003812
[TBL] [Abstract][Full Text] [Related]
23. Genetic susceptibility to HPV infection and cervical cancer.
Maciag PC; Villa LL
Braz J Med Biol Res; 1999 Jul; 32(7):915-22. PubMed ID: 10454752
[TBL] [Abstract][Full Text] [Related]
24. HPV DNA methylation in cervical and head and neck carcinomas.
A Mortaki A; S Mastronikolis N; Tsiambas E; I Pappa K; Ragos V
J BUON; 2018; 23(6):1929-1930. PubMed ID: 30610826
[No Abstract] [Full Text] [Related]
25. Human papillomavirus 16-positive uterine cervical squamous cell carcinoma with coinfection with human papillomavirus 34 has a lower incidence in lymph node metastasis than that without coinfection with human papillomavirus 34.
Michimata R; Watari H; Tomaru U; Sakuragi N; Ishizu A
Pathobiology; 2013; 80(5):259-64. PubMed ID: 23689419
[TBL] [Abstract][Full Text] [Related]
26. Pitfalls in the epidemiologic classification of human papillomavirus types associated with cervical cancer using polymerase chain reaction: driver and passenger.
Matsukura T; Sugase M
Int J Gynecol Cancer; 2008; 18(5):1042-50. PubMed ID: 18248389
[TBL] [Abstract][Full Text] [Related]
27. A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections.
Rousseau MC; Franco EL; Villa LL; Sobrinho JP; Termini L; Prado JM; Rohan TE
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):469-76. PubMed ID: 10815691
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus infection and cervical cancer in Brazil: a retrospective study.
Cavalcanti SM; Deus FC; Zardo LG; Frugulhetti IC; Oliveira LH
Mem Inst Oswaldo Cruz; 1996; 91(4):433-40. PubMed ID: 9070405
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens.
Gupta A; Arora R; Gupta S; Prusty BK; Kailash U; Batra S; Das BC
J Clin Virol; 2006 Nov; 37(3):190-4. PubMed ID: 16931139
[TBL] [Abstract][Full Text] [Related]
30. The Role of HIV in the Progression through the Stages of the Human Papillomavirus to Cervical Cancer Pathway.
Myers KO; Ahmed NU
AIDS Rev; 2018; 20(2):94-1043. PubMed ID: 29938703
[TBL] [Abstract][Full Text] [Related]
31. Distinct geographic clustering of oncogenic human papillomaviruses multiple infections in cervical cancers: Results from a worldwide cross-sectional study.
Pimenoff VN; Tous S; Benavente Y; Alemany L; Quint W; Bosch FX; Bravo IG; de Sanjosé S
Int J Cancer; 2019 May; 144(10):2478-2488. PubMed ID: 30387873
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus genotypes associated with mucopurulent cervicitis and cervical cancer in Hangzhou, China.
Shen XH; Liu SH
Asian Pac J Cancer Prev; 2013; 14(6):3603-6. PubMed ID: 23886152
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus genotype contribution to cervical cancer and precancer: Implications for screening and vaccination in Japan.
Onuki M; Matsumoto K; Iwata T; Yamamoto K; Aoki Y; Maenohara S; Tsuda N; Kamiura S; Takehara K; Horie K; Tasaka N; Yahata H; Takei Y; Aoki Y; Kato H; Motohara T; Nakamura K; Ishikawa M; Kato T; Yoshida H; Matsumura N; Nakai H; Shigeta S; Takahashi F; Noda K; Yaegashi N; Yoshikawa H
Cancer Sci; 2020 Jul; 111(7):2546-2557. PubMed ID: 32372453
[TBL] [Abstract][Full Text] [Related]
34. Cervical cancers associated with human papillomavirus types 16, 18 and 45 are diagnosed in younger women than cancers associated with other types: a cross-sectional observational study in Wales and Scotland (UK).
Powell N; Cuschieri K; Cubie H; Hibbitts S; Rosillon D; De Souza SC; Molijn A; Quint W; Holl K; Fiander A
J Clin Virol; 2013 Nov; 58(3):571-4. PubMed ID: 24051043
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus subtypes distribution among 2309 cervical cancer patients in West China.
Li K; Yin R; Wang D; Li Q
Oncotarget; 2017 Apr; 8(17):28502-28509. PubMed ID: 28415708
[TBL] [Abstract][Full Text] [Related]
36. [Screening of cervical cancer and test for HPV].
Hirai Y
Gan To Kagaku Ryoho; 2010 Feb; 37(2):232-5. PubMed ID: 20235390
[No Abstract] [Full Text] [Related]
37. Studies on the prevalence of oncogenic HPV types among Lithuanian women with cervical pathology.
Simanaviciene V; Gudleviciene Z; Popendikyte V; Dekaminaviciute D; Stumbryte A; Rubinaite V; Zvirbliene A
J Med Virol; 2015 Mar; 87(3):461-71. PubMed ID: 25196501
[TBL] [Abstract][Full Text] [Related]
38. Association of IL-10 GTC haplotype with serum level and HPV infection in the development of cervical carcinoma.
Singhal P; Kumar A; Bharadwaj S; Hussain S; Bharadwaj M
Tumour Biol; 2015 Apr; 36(4):2287-98. PubMed ID: 25412954
[TBL] [Abstract][Full Text] [Related]
39. Regulation of cell cycles is of key importance in human papillomavirus (HPV)-associated cervical carcinogenesis.
Brenna SM; Syrjänen KJ
Sao Paulo Med J; 2003 May; 121(3):128-32. PubMed ID: 12920476
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and genotype identification of human papillomavirus in women undergoing voluntary cervical cancer screening in Molise, central Italy.
Ripabelli G; Grasso GM; Del Riccio I; Tamburro M; Sammarco ML
Cancer Epidemiol; 2010 Apr; 34(2):162-7. PubMed ID: 20080070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
